Perma-Fix Medical
  
    Perma-Fix Medical has developed a breakthrough proprietary process that can be manufactured to support the worldwide shortage of 
    Tc-99m in nuclear medicine. The main shareholder of Perma-Fix Medical is Perma-Fix Environmental Services, Inc., a nuclear services 
    company and leading provider of nuclear and mixed waste management services. Nuclear Medicine uses radiation to provide diagnostic 
    information about the functioning of specific organs, and radiotherapy can be used to treat some medical conditions, especially 
    cancer, using radiation to weaken or destroy particular targeted cells. Tens of millions of nuclear procedures are performed each 
    year driving the demand for radioisotopes. The Perma-Fix Medical solution meets US and global market supply needs for Tc-99m 
    without the use of foreign suppliers of Highly Enriched Uranium (HEU) or Low Enriched Uranium (LEU) targets. In addition, it 
    eliminates environmental concerns associated with the current Mo-99 production methodology, including issues around reprocessing 
    of materials and production of high level waste requiring permanent disposal. 
  
  
  Medical Isotope Production
  
    As an outgrowth of the Environmental business, Perma-Fix developed a proprietary Micro-Porous Composite Material (MPCM). This new class of
    resin is produced from low-cost naturally occurring materials and has the ability to separate heterogeneous mixtures at the atomic level.
  
  
    Completed initial development of a new process to produce Tc-99m for medical diagnostic tests
 
    Expected to solve worldwide shortages of Tc-99m
 
    Far less expensive process and does not require the use of government-subsidized, weapons-grade materials
 
    Designed to improve safety and eliminate proliferation concerns
 
    Process encompasses full production cycle: reactor to final medical supply
 
    - 
      
        Easily deployed around the world using standard research and commercial reactors, thereby eliminates the need for special purpose
        reactors.
      
     
  
  
  
    Dr. Lou Centofanti – Dr. Centofanti has served as Board Chairman since joining Perma-Fix
    Environmental Services Inc., in February 1991. Dr. Centofanti also served as Company President
    and Chief Executive Offcer (February 1991 to September 1995) and again in March 1996 was
    elected Company President and Chief Executive Offcer. From 1985 until joining the Company,
    Dr. Centofanti served as Senior Vice President of USPCI, Inc., a large hazardous waste
    management company, where he was responsible for managing the treatment, reclamation and
    technical groups within USPCI. In 1981 he founded PPM, Inc. (later sold to USPCI), a hazardous
    waste management company specializing in treating PCB contaminated oil. From 1978 to 1981,
    Dr. Centofanti served as Regional Administrator of the U.S. Department of Energy for the
    southeastern region of the United States. Dr. Centofanti has a Ph.D. and a M.S. in Chemistry from
    the University of Michigan, and a B.S. in Chemistry from Youngstown State University.
  
  
    Dr. Centofanti has spent years as a professor and researcher   [1968 – 1979]
    
      - 
        Senior Research Chemist and Environmental Affairs Specialist for Monsanto Chemical
        Company, St. Louis Missouri
 
      - 
        Assistant professor at Emory University , Atlanta, GA where he taught chemistry and
        conducted research and development program in organometallic chemistry
      
 
      - 
        Instructor and research associate in Chemistry at the University of Utah – Salt Lake City,
        Utah
      
 
    
  
  
    Dr. Centofanti is a recognized as a leader in waste reclamation, chemical and energy development in 
    the Southeastern United States.  He has received many awards from the U .S. Department of Energy, and 
    from Mississippi, Florida, Alabama, and Georgia. He has spoken or presented papers at numerous 
    scientific meetings on chemical and energy matters, and has published over 25 papers and patents. 
    He has directed projects in the heavy chemical area and has a great deal of experience with process 
    development and plant construction. Dr. Centofanti has also directed projects in unconventional gas, 
    coal conversion to liquids and gases, eastern oil shale, lubricating oil utilization and PCB chemical 
    destruction.